Cited by CrossRef (1)

Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. Alsharshani, Ali A. Alsayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin. Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?. Clin Med Insights Oncol 2016;10:CMO.S32822